Patrick Van Berkel, PhDSenior Vice President Research and Development at ADC Therapeutics (UK) LimitedSpeaker
Profile
Since August 2012, Patrick van Berkel is appointed as Senior Vice President Research & Development for ADC Therapeutics SA. Between 2003 and 2012, Patrick worked for Genmab BV, where he had various positions with increasing scientific and management responsibilities in the area of antibody engineering and antibody manufacturing. From 2001 to 2003, Patrick worked for Crucell as Senior Scientist Antibody Technology. Patrick worked from 1996 to 2001 for Pharming as scientist protein chemistry. In 1996, Patrick obtained his PhD from the University of Leiden, The Netherlands.